Close Menu

NEW YORK (360Dx) – The US Food and Drug Administration today announced a proposal to exempt certain Class II flow cytometry instruments from the 510(k) process for marketing in the US.

In a statement, the agency said that the proposed exemption would apply only to cytometry instruments that are used for counting or characterizing cells, which it said is a "well-understood and mature technology."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.